SCHEMBL1354897

SCHEMBL1354897

C1=C(c2ccccc2)c2ccccc2OC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 2/20 0.41
OPRK1 P41145 1/20 0.41
KCNH2 Q12809 1/20 0.41
PKM P14618 1/20 0.39
TSHR P16473 1/20 0.39
THRB P10828 1/20 0.38
NPY5R Q15761 1/20 0.36
KMT2A Q03164 2/20 0.36
CYP19A1 P11511 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.34
ITGB2 P05107 1/20 0.34
ICAM1 P05362 1/20 0.34
ITGAL P20701 1/20 0.34
MAPT P10636 3/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6491384 0.84 OPRD1 (0.51) OPRD1OPRK1KCNH2TSHRNPC1
SCHEMBL6478605 0.81 OPRD1 (0.36) OPRD1OPRK1KCNH2PKMTSHR
SCHEMBL6478611 0.81 ELANE (0.39) PKMTSHRKMT2AALDH1A1MAOB
SCHEMBL20346473 0.79 CYP19A1 (0.46) TSHRKMT2ACYP19A1ALDH1A1MAPK1
SCHEMBL6492765 0.79 OPRD1 (0.39) OPRD1OPRK1KCNH2PKMTSHR
SCHEMBL6480972 0.76 OPRD1 (0.55) OPRD1OPRK1KCNH2TSHRKMT2A
SCHEMBL7039789 0.75 PKM (0.42) PKMTSHRKMT2ACYP19A1ALDH1A1
SCHEMBL12365181 0.73 ALDH1A1 (0.43) KMT2AALDH1A1MAPK1PTPRCMEN1
SCHEMBL18766393 0.73 ADRA2A (0.35) TSHRALDH1A1MAPK1MAOB
SCHEMBL8657572 0.73 PKM (0.42) PKMTSHRKMT2ACYP19A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220339178-A1 COMPOSITIONS AND METHODS FOR COGNITIVE PROTECTION OF POLLINATORS AGAINST PESTICIDES COLEGIO MAYOR DE NUESTRA SENORA DEL ROSARIO (CO) 2022-10-27 US disclosed
CN-114524790-A C2 alkynyl disubstituted 2H-chromene compound and preparation method thereof 成都大学 2022-05-24 CN disclosed
EP-3862029-A1 STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES Allergan Industrie, SAS (FR) 2021-08-11 EP disclosed
US-11053471-B1 Method and preparation for the delivery of selective small molecule phytochemical based and pharmacologically active media through a cell membrane to enhance food groups for health protection and benefits SAHA ANUJ K (US) 2021-07-06 US disclosed
WO-2021122481-A1 COMPOSITION COMPRISING A NATURAL DYE AND A FATTY AMINE L'OREAL (FR) 2021-06-24 WO disclosed
EP-3511028-B1 STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES ALLERGAN IND SAS (FR) 2021-04-07 EP disclosed
WO-2021046388-A1 COMPOSITIONS AND METHODS FOR COGNITIVE PROTECTION OF POLLINATORS AGAINST PESTICIDES ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-03-11 WO disclosed
US-10918993-B1 Phipps indoor air filter (PIAF) for capturing and destroying pathogenic viruses like COVID 19 SAHA ANUJ K (US) 2021-02-16 US disclosed
US-20200330358-A1 STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES ALLERGAN INDUSTRIE, SAS (FR) 2020-10-22 US disclosed
US-10806767-B1 Method and preparation for the delivery of selective small molecule phytochemical based and pharmacologically active media through a cell membrane to enhance food groups for health protection and benefits SAHA ANUJ K (US) 2020-10-20 US disclosed
US-7064543-B2 Method of verifying the synthesis of organic molecules using nuclear magnetic resonance spectroscopy BRUKER BIOSPIN GMBH (DE) 2006-06-20 US disclosed
US-20040096905-A1 Using spectrum analysis to monitor and evaluate production of compounds within a library of organic compounds produced by combinatorial chemistry; high throughput assay BRUKER ANALYTIK GMBH (DE) 2004-05-20 US disclosed
US-6596758-B1 Treatment of dislipidaemias, atherosclerosis and diabetes, to pharmaceutical compositions comprising them and to processes allowing the preparation of these compounds. MERCK PATENT GMBH (DE) 2003-07-22 US disclosed
EP-1140893-B1 BENZOPYRANS AND BENZOXEPINES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-05 EP disclosed
US-6509362-B2 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis. MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2003-01-21 US disclosed
US-20020068739-A1 New N-phenylamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2002-06-06 US disclosed
US-6339097-B1 FOR THERAPY OF HYPERLIPIDAEMIA AND ATHEROSCLEROSIS; CHOLESTERYL ACYL TRANSFERASE (ACAT) INHIBITORS MERCK PATENT GMBH (DE) 2002-01-15 US disclosed
US-20020001816-A1 Method of verifying the synthesis of organic molecules using nuclear magnetic resonance spectroscopy BRUKER ANALYTIK GMBH (DE) 2002-01-03 US disclosed
EP-1140893-A1 BENZOPYRANS AND BENZOXEPINES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PREPARATION PROCESS MERCK PATENT GmbH (DE) 2001-10-10 EP disclosed
WO-2000039113-A1 BENZOPYRANS AND BENZOXEPINES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2000-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020068739-A1 New N-phenylamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them ACAT2, LCAT, ACAT1 OPRD1 2599/4885OPRK1 3151/4885KCNH2 2899/4885
US-20220339178-A1 COMPOSITIONS AND METHODS FOR COGNITIVE PROTECTION OF POLLINATORS AGAINST PESTICIDES ACHE, BCHE, GAP43 OPRD1 989/4885OPRK1 741/4885KCNH2 607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.